Table 4 Results of Sensitivity Analyses
1:1 Propensity Score Matching | On-Treatment Approach | |
|---|---|---|
3-Month | ||
Composite of recurrent venous thromboembolism or major bleeding | 1.10 (0.82–1.46) | 1.10 (0.83–1.45) |
Recurrent venous thromboembolism | 1.08 (0.78–1.50) | 1.11 (0.81–1.52) |
Major bleeding | 1.28 (0.73–2.25) | 1.17 (0.69–1.98) |
Intracranial hemorrhage | 1.04 (0.15–7.37) | 0.65 (0.12–3.47) |
Gastrointestinal bleeding | 1.11 (0.56–2.19) | 1.08 (0.55–2.13) |
Genitourinary bleeding | 1.39 (0.31–6.21) | 1.05 (0.29–3.75) |
6-Month | ||
Composite of recurrent venous thromboembolism or major bleeding | 1.00 (0.767–1.31) | 1.05 (0.81–1.37) |
Recurrent venous thromboembolism | 1.04 (0.76–1.41) | 1.12 (0.83–1.53) |
Major bleeding | 1.02 (0.62–1.69) | 1.01 (0.62–1.66) |
Intracranial hemorrhage | 0.70 (0.12–4.20) | 0.65 (0.12–3.47) |
Gastrointestinal bleeding | 0.80 (0.43–1.47) | 0.94 (0.50–1.78) |
Genitourinary bleeding | 1.39 (0.31–6.21) | 0.85 (0.25–2.84) |
12-Month | ||
Composite of recurrent venous thromboembolism or major bleeding | 0.98 (0.76–1.25) | 1.04 (0.80–1.34) |
Recurrent venous thromboembolism | 1.00 (0.75–1.34) | 1.10 (0.82–1.47) |
Major bleeding | 0.99 (0.64–1.5) | 0.98 (0.61–1.57) |
Intracranial hemorrhage | 0.94 (0.29–3.10) | 0.82 (0.21–3.30) |
Gastrointestinal bleeding | 0.84 (0.47–1.48) | 0.88 (0.47–1.65) |
Genitourinary bleeding | 1.34 (0.36–5.00) | 1.03 (0.33–3.24) |